A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology. 1996 Oct;48(4):661-3. doi: 10.1016/s0090-4295(96)80033-1.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Comparative Study
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Androgen Antagonists / administration & dosage
  • Anilides / administration & dosage
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Controlled Clinical Trials as Topic
  • Flutamide / administration & dosage
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Humans
  • Male
  • Nitriles
  • Prostatic Neoplasms / drug therapy*
  • Tosyl Compounds

Substances

  • Androgen Antagonists
  • Anilides
  • Antineoplastic Agents, Hormonal
  • Nitriles
  • Tosyl Compounds
  • Gonadotropin-Releasing Hormone
  • Flutamide
  • bicalutamide